These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 18464763)

  • 1. Microbiologically Controlled Products: Regulatory Management of Postapproval Changes.
    McDonnell G; Baseman H; Cordie-Bancroft L
    Biomed Instrum Technol; 2023; 57(1):8-17. PubMed ID: 36753632
    [No Abstract]   [Full Text] [Related]  

  • 2. Rebates for anti-anemia drugs draw response from FDA, CMS.
    Sipkoff M
    Manag Care; 2007 Jun; 16(6):17-8. PubMed ID: 17682732
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. FDA issues public health advisory about ESAs.
    AIDS Alert; 2007 May; 22(5):57-8. PubMed ID: 17580370
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA likely to further restrict erythropoietin use for cancer patients.
    Fox JL
    Nat Biotechnol; 2007 Jun; 25(6):607-8. PubMed ID: 17557084
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin, the FDA, and oncology.
    Steinbrook R
    N Engl J Med; 2007 Jun; 356(24):2448-51. PubMed ID: 17568025
    [No Abstract]   [Full Text] [Related]  

  • 6. ESAs further restricted, but debate continues.
    Brower V
    J Natl Cancer Inst; 2008 Oct; 100(19):1344-51. PubMed ID: 18812542
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies to optimize the use of erythropoietin and iron therapy in oncology patients.
    Ford PA; Mastoris J
    Transfusion; 2004 Dec; 44(12 Suppl):15S-25S. PubMed ID: 15585001
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin: the swinging pendulum.
    Oster HS; Neumann D; Hoffman M; Mittelman M
    Leuk Res; 2012 Aug; 36(8):939-44. PubMed ID: 22579365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of erythropoiesis stimulating agents in patients on dialysis: current issues for nephrology nurses.
    Carter B; Keen M
    Nephrol Nurs J; 2007; 34(3):311-5. PubMed ID: 17644875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances on the use of erythropoietin in oncology].
    Spaëth D
    Bull Cancer; 2006 May; 93(5):489-93. PubMed ID: 16777627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes for ESAs.
    Spalding BJ
    Nat Biotechnol; 2008 May; 26(5):483. PubMed ID: 18464763
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.